Novel Chinese Angelica Polysaccharide Biomimetic Nanomedicine to Curcumin Delivery for Hepatocellular Carcinoma Treatment and Immunomodulatory Effect
- PMID: 33039729
- DOI: 10.1016/j.phymed.2020.153356
Novel Chinese Angelica Polysaccharide Biomimetic Nanomedicine to Curcumin Delivery for Hepatocellular Carcinoma Treatment and Immunomodulatory Effect
Abstract
Background: Using natural polysaccharides from Traditional Chinese Medicine as nanodrug delivery systems have considerable potential for tumor diagnostics and therapeutics.
Purpose: On the basis of targeted therapy and combining the advantages of natural polysaccharides (angelica polysaccharide, APS) and natural Chinese medicine (curcumin, Cur) to design functionalized nanoparticles to improve the therapeutic through cell membrane encapsulation and immunotherapy.
Study design and methods: Cur-loaded, glycyrrhetic acid (GA)-APS-disulfide bond (DTA)-Cur nanomicelle (GACS-Cur), which were prepared by the dialysis method. GACS-Cur was encapsulated with the membranes from red blood cells (RBCm) termed GACS-Cur@RBCm, which were prepared by the principle of extrusion using a miniature extruder. The developed formulations were subjected to various in vitro and in vivo evaluation tests.
Results: The resulting APS nanocarriers supported a favorable drug-loading capacity, biocompatibility, and enhanced synergistic anti-hepatoma effects both in vitro and in vivo. After administration in mice, in vivo imaging results showed that the GACS-Cur and RBCm-coated groups had an obvious stronger tumor tissue targeting ability than the control treatment groups. Additionally, the immunomodulatory effect increased IL-12, TNF-α and IFN-γ expression and CD8+ T cell infiltration (1.9-fold) than that of the saline group. Notably, in comparison with hyaluronic acid (HA) nanocarriers, APS nanocarriers possess higher anti-hepatoma efficiency and targeting capabilities and, thus, should be further studied for a wide range of anti-cancer applications.
Conclusion: Our data demonstrated that APS nanocarriers encapsulated with erythrocyte membrane mighty be a promising clinical method in the development of efficacy, safety and targeting of liver cancer therapy.
Keywords: Angelica polysaccharide; Anti-hepatoma; Immunomodulatory effect; Liver targeting; Natural polysaccharides; Redox sensitive nanovesicles.
Copyright © 2020 Elsevier GmbH. All rights reserved.
Similar articles
-
Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.Int J Pharm. 2018 Jul 10;545(1-2):261-273. doi: 10.1016/j.ijpharm.2018.05.007. Epub 2018 May 3. Int J Pharm. 2018. PMID: 29730175
-
Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.Eur J Pharm Biopharm. 2015 Jun;93:27-36. doi: 10.1016/j.ejpb.2015.03.003. Epub 2015 Mar 11. Eur J Pharm Biopharm. 2015. PMID: 25770771
-
Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.Int J Nanomedicine. 2018 Dec 6;13:8309-8323. doi: 10.2147/IJN.S184379. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30584302 Free PMC article.
-
Antitumor immunostimulatory activity of the traditional Chinese medicine polysaccharide on hepatocellular carcinoma.Front Immunol. 2024 Feb 22;15:1369110. doi: 10.3389/fimmu.2024.1369110. eCollection 2024. Front Immunol. 2024. PMID: 38455058 Free PMC article. Review.
-
Polysaccharide mediated nanodrug delivery: A review.Int J Biol Macromol. 2024 Mar;261(Pt 1):129547. doi: 10.1016/j.ijbiomac.2024.129547. Epub 2024 Jan 24. Int J Biol Macromol. 2024. PMID: 38278399 Review.
Cited by
-
Angelica Sinensis Polysaccharide-Based Nanoparticles for Liver-Targeted Delivery of Oridonin.Molecules. 2024 Feb 5;29(3):731. doi: 10.3390/molecules29030731. Molecules. 2024. PMID: 38338476 Free PMC article.
-
Protective role of curcumin in disease progression from non-alcoholic fatty liver disease to hepatocellular carcinoma: a meta-analysis.Front Pharmacol. 2024 Jan 19;15:1343193. doi: 10.3389/fphar.2024.1343193. eCollection 2024. Front Pharmacol. 2024. PMID: 38313314 Free PMC article.
-
Recent advances of novel targeted drug delivery systems based on natural medicine monomers against hepatocellular carcinoma.Heliyon. 2024 Jan 18;10(2):e24667. doi: 10.1016/j.heliyon.2024.e24667. eCollection 2024 Jan 30. Heliyon. 2024. PMID: 38312669 Free PMC article. Review.
-
The potential immuno-stimulating effect of curcumin, piperine, and taurine combination in hepatocellular carcinoma; a pilot study.Discov Oncol. 2023 Sep 13;14(1):169. doi: 10.1007/s12672-023-00785-1. Discov Oncol. 2023. PMID: 37704828 Free PMC article.
-
Structural characterization and anti-inflammatory activity of a novel polysaccharide PKP2-1 from Polygonatum kingianum.Front Nutr. 2023 Mar 27;10:1156798. doi: 10.3389/fnut.2023.1156798. eCollection 2023. Front Nutr. 2023. PMID: 37051130 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
